UK investors are buying Fulgent and Carnival shares, says Fineco

UK investors are looking at the US market for top growth opportunities, according to the latest data from trading platform Fineco.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Buying US shares is easier than ever for UK investors. Share trading platform Fineco says that top US healthcare and pharma stocks were among the most popular with UK investors last week.

Topping the list was biotech company Fulgent Genetics. NASDAQ-listed Fulgent is heavily involved in Covid-19 testing and recently reported a 3,400% increase in quarterly revenue.

Another big trend highlighted by Fineco’s data was the trade in reopening stocks. This included big names in the US and UK travel sectors, such as Carnival and Rolls-Royce.

Here’s my take on the biggest movers reported by Fineco this week.

US shares lead the way

UK traders on Fineco’s platform seem to be spending a lot of their time focusing on fast-moving US stocks. The top five movers last week were all US-listed firms in the pharma and tech sectors.

In first place was Fulgent Genetics. This company specialises in genetic testing that provides clinically actionable information. But it’s Fulgent’s success in Covid-19 testing that has boosted its share price by 760% over the last year.

Fulgent says that revenue rose by 1,200% to $422m in 2020. The firm expects this figure to rise by 90% to $800m in 2021, including $70m from its next generation sequencing genetic testing service.

Fulgent shares are priced on a modest multiple of 8.5 times 2021 forecast earnings, but brokers expect earnings to fall by 70% in 2022 as the Covid-19 pandemic recedes.

Other top US stocks that were heavily traded by Fineco’s UK investor clients last week included vaccine firm Moderna, Regeneron Pharmaceuticals, and China-based tech stocks SOS Ltd and Lizhi Inc.

Two notable names that were out of favour were Airbnb and Germany car stock Volkswagen. Both were sold heavily on the Fineco platform last week.

UK investors buy reopening stocks

What about UK shares? Fineco’s traders showed plenty of interest in their home market too. Reopening stocks led the way. These are companies that are expected to benefit from a return to normal as the UK exits lockdown.

The world’s largest cruise ship operator, Carnival, was one of Fineco’s top UK movers. Other stocks that caught buyers’ interest included The Gym Group and budget airline Wizz Air.

Travel and leisure weren’t the only themes. Gold miners Centamin and Polymetal International both saw strong buying on Fineco. Both of these big producers have reported solid financial results recently.

Centamin’s net profit rose by 78% to $156m last year, while Polymetal’s earnings rose by 125% to $1,086m. The outlook is positive for both businesses, according to their respective CEOs.

Elsewhere, the prospects for housebuilders seemed to divide opinion among Fineco’s UK investors. Investors bought and sold equal volumes of shares in housebuilder Crest Nicholson last week.

Outsourcer Serco Group received a similar split decision, but investors turned cautious on grocer Wm Morrisons Supermarkets. Investors trading the Bradford-based supermarket’s shares sold two shares for every one they bought. I think this weakness could reflect concerns that shoppers will start spending more widely as the economy reopens.

Roland Head owns shares of Polymetal International. The Motley Fool UK owns shares of and has recommended Fulgent Genetics, Inc. The Motley Fool UK has recommended Airbnb, Inc., Moderna Inc., Morrisons, The Gym Group, and Wizz Air Holdings. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Middle-aged white man pulling an aggrieved face while looking at a screen
Market Movers

Down 7%! Why on earth are Imperial Brands shares plummeting today?

Imperial Brands shares are in freefall after a negative reception to fresh trading news. Is the party finally over for…

Read more »

Rear View Of Woman Holding Man Hand during travel in cappadocia
Investing Articles

With a P/E under 7, this value stock looks far too cheap at 101p

This writer reckons value stock Hostelworld (LSE:HSW) looks dirt-cheap as it gets dividends flowing again and builds a social travel…

Read more »

Thoughtful man using his phone while riding on a train and looking through the window
Investing For Beginners

Down 30% in 6 months, I think there’s a big catch to this insanely cheap stock

Jon Smith talks through why careful research is needed when trying to assess if a cheap stock is worth buying…

Read more »

Investing Articles

£5,000 invested in National Grid shares 5 years ago is now worth…

Andrew Mackie takes a closer look at National Grid shares and why short-term market weakness could be missing a powerful…

Read more »

DIVIDEND YIELD text written on a notebook with chart
Investing Articles

How big does an ISA need to be to aim for a £1,500 monthly second income?

Harvey Jones shows how building a balanced portfolio of FTSE 100 dividend stocks can produce a high-and-rising second income in…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

£20,000 invested in BP shares 1 year ago is now worth…

BP shares have rocketed in the past 12 months, yet analysts think the real growth story is only just beginning,…

Read more »

A pastel colored growing graph with rising rocket.
Investing Articles

A 6.8% forecast yield! 1 often-overlooked FTSE 100 income stock to buy today?

This income stock offers a high forecast yield and strengthening momentum, yet many investors overlook it — creating a rare…

Read more »

GSK scientist holding lab syringe
Investing Articles

GSK’s share price is under £22, but with a ‘fair value’ much higher, is it time for me to buy more right now? 

GSK’s share price rose over the last year, but a huge gap remains between its price and fair value —…

Read more »